United Kingdom-based Senzer's pharmaceutical cannabinoid device has received another major design award from the German Design Council, it was reported on Friday.
The award was conferred on the company's unique inhaler for having 'a clear modern design that perfectly combines ergonomics and functionality'. It is the third design success for Senzer's Class IIa Medical Device, which is breath-activated and delivers a precise dose of pharmaceutical cannabinoids, and has been used in a clinical setting for treating side effects linked to cancer treatment. The company received the honour for Excellent Product Design in the category of 'Medical, Rehabilitation and Health Care'
The German Design Council stated that the criteria for the award was for 'projects that truly represent pioneering contributions to the German and international design landscape.'
Halma acquires Rovers Medical Devices
boston Scientific granted FDA approval for AGENT Drug-Coated Balloon
Enable Injections names new chief operating officer
BridgeBio Pharma and Kyowa Kirin partner on infigratinib for skeletal dysplasias in Japan
Redwood Scientific signs agreement with Jeeva Clinical Trials
Tissue Regenix ships first allograft products in the EU post-HPRA approval
Kromek secures GBP1.3m grant for AI-powered radiation sensor project